These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 8648668)

  • 61. Elimination of protease activity restores efficient virion production to a human immunodeficiency virus type 1 nucleocapsid deletion mutant.
    Ott DE; Coren LV; Chertova EN; Gagliardi TD; Nagashima K; Sowder RC; Poon DT; Gorelick RJ
    J Virol; 2003 May; 77(10):5547-56. PubMed ID: 12719547
    [TBL] [Abstract][Full Text] [Related]  

  • 62. HIV-1 Gag Recruits Oligomeric Vpr via Two Binding Sites in p6, but Both Mature p6 and Vpr Are Rapidly Lost upon Target Cell Entry.
    Wanaguru M; Bishop KN
    J Virol; 2021 Aug; 95(17):e0055421. PubMed ID: 34106747
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Proteolytic cleavage at the Gag-Pol junction in avian leukosis virus: differences in vitro and in vivo.
    Stewart L; Vogt VM
    Virology; 1994 Oct; 204(1):45-59. PubMed ID: 7522375
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A virion-specific inhibitory molecule with therapeutic potential for human immunodeficiency virus type 1.
    Matsuda Z; Yu X; Yu QC; Lee TH; Essex M
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3544-8. PubMed ID: 7682710
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles.
    Lavallée C; Yao XJ; Ladha A; Göttlinger H; Haseltine WA; Cohen EA
    J Virol; 1994 Mar; 68(3):1926-34. PubMed ID: 8107252
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The virus-associated human immunodeficiency virus type 1 Gag-Pol carrying an active protease domain in the matrix region is severely defective both in autoprocessing and in trans processing of gag particles.
    Chen SW; Chiu HC; Liao WH; Wang FD; Chen SS; Wang CT
    Virology; 2004 Jan; 318(2):534-41. PubMed ID: 14972522
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The stability of HIV-2 Vpx and Vpr proteins is regulated by the presence or absence of zinc-binding sites and poly-proline motifs with distinct roles.
    Shimagaki K; Koga R; Fujino H; Ahagon A; Tateishi H; Otsuka M; Yamaguchi Y; Fujita M
    J Gen Virol; 2020 Sep; 101(9):997-1007. PubMed ID: 32553018
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of linker insertion mutations in the human immunodeficiency virus type 1 gag gene on activation of viral protease expressed in bacteria.
    Luban J; Lee C; Goff SP
    J Virol; 1993 Jun; 67(6):3630-4. PubMed ID: 8497070
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cell cycle inhibitory effects of HIV and SIV Vpr and Vpx in the yeast Schizosaccharomyces pombe.
    Zhang C; Rasmussen C; Chang LJ
    Virology; 1997 Mar; 230(1):103-12. PubMed ID: 9126266
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Generation of infectious virus particles by transient co-expression of human immunodeficiency virus type 1 gag mutants.
    Chen YL; Ts'ai PW; Yang CC; Wang CT
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2497-501. PubMed ID: 9349470
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A non-canonical transferable signal mediates nuclear import of simian immunodeficiency virus Vpx protein.
    Rajendra Kumar P; Singhal PK; Vinod SS; Mahalingam S
    J Mol Biol; 2003 Aug; 331(5):1141-56. PubMed ID: 12927548
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Context surrounding processing sites is crucial in determining cleavage rate of a subset of processing sites in HIV-1 Gag and Gag-Pro-Pol polyprotein precursors by viral protease.
    Lee SK; Potempa M; Kolli M; Özen A; Schiffer CA; Swanstrom R
    J Biol Chem; 2012 Apr; 287(16):13279-90. PubMed ID: 22334652
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures.
    Liu H; Wu X; Newman M; Shaw GM; Hahn BH; Kappes JC
    J Virol; 1995 Dec; 69(12):7630-8. PubMed ID: 7494271
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
    Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
    Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Contribution of the Gag-Pol transframe domain p6* and its coding sequence to morphogenesis and replication of human immunodeficiency virus type 1.
    Paulus C; Ludwig C; Wagner R
    Virology; 2004 Dec; 330(1):271-83. PubMed ID: 15527852
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutations.
    Kiernan RE; Freed EO
    J Virol; 1998 Dec; 72(12):9621-7. PubMed ID: 9811695
    [TBL] [Abstract][Full Text] [Related]  

  • 77. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.
    Huang M; Orenstein JM; Martin MA; Freed EO
    J Virol; 1995 Nov; 69(11):6810-8. PubMed ID: 7474093
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles.
    Karacostas V; Wolffe EJ; Nagashima K; Gonda MA; Moss B
    Virology; 1993 Apr; 193(2):661-71. PubMed ID: 7681610
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation.
    Quillent C; Borman AM; Paulous S; Dauguet C; Clavel F
    Virology; 1996 May; 219(1):29-36. PubMed ID: 8623542
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mechanism of inhibition of the retroviral protease by a Rous sarcoma virus peptide substrate representing the cleavage site between the gag p2 and p10 proteins.
    Cameron CE; Grinde B; Jentoft J; Leis J; Weber IT; Copeland TD; Wlodawer A
    J Biol Chem; 1992 Nov; 267(33):23735-41. PubMed ID: 1331099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.